- Report
- August 2022
- 111 Pages
Europe
From €1442EUR$1,500USD£1,237GBP
- Report
- August 2022
- 111 Pages
Middle East, Africa
From €1442EUR$1,500USD£1,237GBP
- Report
- March 2024
- 48 Pages
Côte d'Ivoire
From €1675EUR$1,866USD£1,487GBP
- Report
- February 2024
- 24 Pages
China, Hong Kong
From €825EUR$919USD£733GBP
- Report
- January 2024
- 91 Pages
Nigeria
From €2200EUR$2,451USD£1,953GBP
- Report
- December 2023
- 112 Pages
Germany
From €2200EUR$2,451USD£1,953GBP
- Report
- November 2023
- 25 Pages
India
From €825EUR$919USD£733GBP
- Report
- October 2023
- 118 Pages
Japan
From €2200EUR$2,451USD£1,953GBP
- Report
- October 2023
- 99 Pages
South Africa
From €2200EUR$2,451USD£1,953GBP
- Report
- October 2023
- 111 Pages
Malaysia
From €2200EUR$2,451USD£1,953GBP
- Report
- October 2023
- 26 Pages
Mexico
From €825EUR$919USD£733GBP
- Report
- October 2023
- 22 Pages
Uzbekistan
From €825EUR$919USD£733GBP
- Report
- October 2023
- 23 Pages
Azerbaijan
From €825EUR$919USD£733GBP
- Report
- October 2023
- 29 Pages
South Korea
From €825EUR$919USD£733GBP
- Report
- October 2023
- 112 Pages
South Korea
From €2200EUR$2,451USD£1,953GBP
- Report
- October 2023
- 72 Pages
Pakistan
From €2200EUR$2,451USD£1,953GBP
- Report
- October 2023
- 53 Pages
Laos
From €1675EUR$1,866USD£1,487GBP
- Report
- September 2023
- 110 Pages
Spain
From €2200EUR$2,451USD£1,953GBP
- Report
- September 2023
- 115 Pages
Portugal
From €2200EUR$2,451USD£1,953GBP
- Report
- September 2023
- 26 Pages
Colombia
From €825EUR$919USD£733GBP
Allergic Rhinitis is a condition that affects the nose and is caused by an allergic reaction to certain substances. Over the Counter (OTC) drugs are used to treat the symptoms of Allergic Rhinitis, such as sneezing, runny nose, and itchy eyes. OTC drugs are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. Common active ingredients in OTC drugs for Allergic Rhinitis include antihistamines, decongestants, and corticosteroids. These drugs can be used to reduce inflammation, relieve congestion, and reduce the severity of symptoms.
Some companies in the Allergic Rhinitis Drug market include Johnson & Johnson, GlaxoSmithKline, Novartis, Merck, and Sanofi. Show Less Read more